Duchenne and Becker Muscular Dystrophy
1 clinical trials · Condition
◉ Watch Duchenne and Becker Muscular Dystrophy
| Record | Firm | Date |
|---|---|---|
| Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval (NCT04821063) | Italfarmaco | 2021-04-13 |
Track Duchenne and Becker Muscular Dystrophy automatically
Every clearance here is in the API, with alerts when new ones post.